-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professional reading reference only
At the end of the article, there is a wonderful comment from Professor Dong Qiang of Huashan Hospital Affiliated to Fudan University, don't miss it~
Published July 9, 2022 under the title "Thrombectomy alone versus intravenous alteplase plus thrombectomy in stroke patients: an open-label, blinded outcome, randomized noninferiority trial.
Figure 1.
Figure 2.
July 9, 2022, under the title "Endovascular thrombectomy versus standard bridging thrombolysis plus endovascular thrombectomy within 4.
Figure 3.
Figure 4.
Professor Dong Qiang
Reference source:
[1]can I find more clinical knowledge of neurology?
Source of this articleMedical Neurology Channel This article author | I hope this article will be reviewed | Professor Dong Qiang
Editor-in-charge of Huashan Hospital Affiliated to Fudan UniversityMr.
Lu Li
Copyright statement
This article is original, for reprinting, please contact Authorization-End-Submission/reprinting/business cooperation, please contact: yxjsjbx@yxj.
org.
cn the timeliness, and the accuracy and completeness of the cited materials (if any), etc.
, and do not undertake any commitments and guarantees caused by the outdated contents, the possible inaccuracy or incompleteness of the cited materials, etc.
responsibility
.
Relevant parties are requested to check separately when adopting or using it as a basis for decision-making
.
